[HTML][HTML] Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
M Trimboli, P Zoleo, G Arabia, A Gambardella - Neurological Sciences, 2021 - Springer
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
[引用][C] Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
M Trimboli, P Zoleo, G Arabia… - … : official journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine Guillain-Barré syndrome
following BNT162b2 COVID-19 vaccine Neurol Sci. 2021 Nov;42(11):4401-4402. doi …
following BNT162b2 COVID-19 vaccine Neurol Sci. 2021 Nov;42(11):4401-4402. doi …
[PDF][PDF] Guillain‑Barré syndrome following BNT162b2 COVID‑19 vaccine
M Trimboli, P Zoleo, G Arabia, A Gambardella - 2021 - academia.edu
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
[HTML][HTML] Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
M Trimboli, P Zoleo, G Arabia… - Neurological …, 2021 - ncbi.nlm.nih.gov
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine.
M Trimboli, P Zoleo, G Arabia… - … : Official Journal of the …, 2021 - europepmc.org
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
[PDF][PDF] Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
M Trimboli, P Zoleo, G Arabia, A Gambardella - 2021 - researchgate.net
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
M Trimboli, Z Pio, A Gennarina… - Neurological …, 2021 - search.proquest.com
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
[引用][C] Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
M Trimboli, P Zoleo, G Arabia… - NEUROLOGICAL …, 2021 - iris.unicz.it
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …
[PDF][PDF] Guillain‑Barré syndrome following BNT162b2 COVID‑19 vaccine
M Trimboli, P Zoleo, G Arabia, A Gambardella - 2021 - academia.edu
Guillain-Barré syndrome (GBS) is the most common and severe acute paralytic neuropathy,
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …
with about 100,000 people developing the disorder every year worldwide [1]. Up to two …